PARTNERING WITH PATrOL™ TO HELP MORE PATIENTS

We believe that the best way to help the largest number of patients is to develop strategic partnerships, research collaborations, and licensing arrangements. The breadth of NeuBase's proprietary PATrOL™ platform gives us the unique ability to tackle a multitude of genetic diseases, from rare to common. While we intend to advance an extensive pipeline of therapies ourselves, we are open to discussing opportunities to utilize our PATrOL platform across multiple organ systems and disease indications.